Tag Archives: TG Therapeutics

Raymond James Maintains Their Buy Rating on TG Therapeutics

Raymond James analyst Reni Benjamin maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX) yesterday. The company’s shares closed yesterday at $14.35. Benjamin observed: “We are maintaining our Strong Buy rating for TG Therapeutics. Today, at the American Academy of

TG Therapeutics Receives a Buy from Raymond James

Raymond James analyst Reni Benjamin reiterated a Buy rating on TG Therapeutics (NASDAQ: TGTX) today. The company’s shares opened today at $14.20. Benjamin noted: “We are reiterating our Strong Buy rating on TG Therapeutics. At the 2018 American Association of

Raymond James Believes TG Therapeutics (NASDAQ: TGTX) Won’t Stop Here

Raymond James analyst Reni Benjamin maintained a Buy rating on TG Therapeutics (NASDAQ: TGTX) today and set a price target of $22. The company’s shares closed yesterday at $16.45, close to its 52-week high of $16.90. Benjamin observed: “We are

TG Therapeutics Receives a Buy from B.Riley FBR

B.Riley FBR analyst Madhu Kumar reiterated a Buy rating on TG Therapeutics (NASDAQ: TGTX) today and set a price target of $21.50. The company’s shares opened today at $11.85. Kumar said: “This morning, 2/2, TG Therapeutics announced additional data from

TG Therapeutics Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Edward White assigned a Buy rating to TG Therapeutics (NASDAQ: TGTX) today and set a price target of $33. The company’s shares opened today at $9.20. White said: “TG Announces Global License Agreement With Jiangsu Hengrui Medicine

B.Riley FBR Assigns a Buy Rating on TG Therapeutics

In a report released yesterday, Madhu Kumar from B.Riley FBR assigned a Buy rating to TG Therapeutics (NASDAQ: TGTX), with a price target of $21.50. The company’s shares closed yesterday at $8.60. Kumar wrote: “We are resuming coverage of TG